Notice Title

Consent to the Distribution of New Medicines

Publication Date
30 Apr 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl2271
Title
View PDF
File Type and Size
PDF (25 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Eltrombopag-Teva
Active Ingredient: Eltrombopag olamine 31.9mg equivalent to eltrombopag 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Watson Pharma Private Limited, Verna, India
   
Product: Eltrombopag-Teva
Active Ingredient: Eltrombopag olamine 63.8mg equivalent to eltrombopag 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Watson Pharma Private Limited, Verna, India
   
Product: Entyvio (Pre-filled Syringe)
Active Ingredient: Vedolizumab 160mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Entyvio (Pre-filled Pen)
Active Ingredient: Vedolizumab 160mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Paclitaxel Accord (30mg/5mL)
Active Ingredient: Paclitaxel 6mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India
   
Product: Paclitaxel Accord (100mg/16.7mL)
Active Ingredient: Paclitaxel 6mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India
   
Product: Paclitaxel Accord (300mg/50mL)
Active Ingredient: Paclitaxel 6mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India
   
Product: Sapropterin ADVZ
Active Ingredient: Sapropterin dihydrochloride 100mg
Dosage Form: Soluble tablet
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
Manufacturer: Zenara Pharma Pvt. Limited, Hyderabad, India


Dated this 28th day of April 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).